Amgen Inc
LSE:0R0T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amgen Inc
LSE:0R0T
|
US |
|
L
|
Liberty Latin America Ltd
NASDAQ:LILAK
|
US |
|
D
|
Daya Intiguna Yasa Tbk PT
IDX:MDIY
|
ID |
|
Nikon Corp
F:NKN0
|
JP |
Wall St Price Targets
0R0T Price Targets Summary
Amgen Inc
According to Wall Street analysts, the average 1-year price target for 0R0T is 368.1 USD with a low forecast of 201.5 USD and a high forecast of 447.23 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0R0T's stock price target?
Price Target
368.1
USD
According to Wall Street analysts, the average 1-year price target for 0R0T is 368.1 USD with a low forecast of 201.5 USD and a high forecast of 447.23 USD.
What is the Revenue forecast for Amgen Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Amgen Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Amgen Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Amgen Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Amgen Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 10%.
